Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Thoracic 4Head & Neck 4Gynecologic 4Lymphoid 3Dermatologic 3Other hematologic neoplasm 2Genitourinary 2Gastrointestinal 2CNS 2Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 2Neoplasm Metastasis 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × NVP-BKM120 × Genitourinary × Clear all
NCT01695473 2021-01-13

Neoadjuvant BKM120 in High-risk Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
11 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT01385293 2017-05-19

BKM120 in Metastatic Castration-resistant Prostate Cancer

Duke University

Phase 2 Terminated
30 enrolled 11 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡